LJ
SSY Group Limited
LJUIF · OTC
$0.40 +0.00% (+$0.00)
Market Cap $9.32B
P/E Ratio 19.81x
Div. Yield 2.69%
ROE 6.36%
Bulios Fair Price
$0.47
16.7% upside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LJUIF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair P/FCF 31.10x
P/E 19.81x
P/B 1.28x
Growth
5 /100
Declining FCF growth 6.67%
EPS growth 25.05%
Book val. growth 5.51%
Profitability
57 /100
Moderate Op. margin 9.75%
Gross margin 38.92%
FCF margin 7.20%
Quality
23 /100
Poor ROA 3.67%
ROIC 2.91%
Asset turnover 0.33x
Debt
64 /100
Moderate Int. coverage 3.85x
Debt/Equity 0.55x
Net debt/EBITDA 2.61x
Stability
75 /100
Stable EPS volatility 35.69%
Beta 0.53x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LJUIF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ji Guang Qu
Employees
5,500
Headquarters
Hong Kong
Upcoming events
26 MAR
Earnings
Upcoming earnings report